Abstract
The activity of the transcription factor NF-kappaB is thought to be regulated mainly through cytoplasmic retention by IkappaB molecules. Here we present evidence of a second mechanism of regulation acting on NF-kappaB after release from IkappaB. In endothelial cells this mechanism involves phosphorylation of the RelA subunit of NF-kappaB through a pathway involving activation of protein kinase Czeta (PKCzeta) and p21(ras). We show that transcriptional activity of RelA is dependent on phosphorylation of the N-terminal Rel homology domain but not the C-terminal transactivation domain. Inhibition of phosphorylation by dominant negative mutants of PKCzeta or p21(ras) results in loss of RelA transcriptional activity without interfering with DNA binding. Raf/MEK, small GTPases, phosphatidylinositol 3-kinase, and stress-activated protein kinase pathways are not involved in this mechanism of regulation.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Base Sequence
-
Cattle
-
Cells, Cultured
-
DNA Primers
-
Endothelium, Vascular / cytology
-
Endothelium, Vascular / enzymology
-
Endothelium, Vascular / metabolism*
-
GTP Phosphohydrolases / metabolism
-
Humans
-
Molecular Sequence Data
-
NF-kappa B / antagonists & inhibitors
-
NF-kappa B / metabolism*
-
Oncogene Protein p21(ras) / metabolism*
-
Phosphatidylinositol 3-Kinases / metabolism
-
Phosphorylation
-
Protein Kinase C / metabolism*
-
Proto-Oncogene Proteins c-raf / metabolism
-
Signal Transduction
-
Swine
-
Transcription Factor RelA
-
Transcription, Genetic*
-
Tumor Necrosis Factor-alpha / pharmacology
Substances
-
DNA Primers
-
NF-kappa B
-
Transcription Factor RelA
-
Tumor Necrosis Factor-alpha
-
Phosphatidylinositol 3-Kinases
-
Proto-Oncogene Proteins c-raf
-
protein kinase C zeta
-
Protein Kinase C
-
GTP Phosphohydrolases
-
Oncogene Protein p21(ras)